Sign up to receive our twice-weekly e-Newsletter
HIV
and
Hepatitis
.com
PRO 140 and PRO 2000
PRO 140
is a humanized monoclonal antibody designed to block the ability of HIV to infect cells by inhibiting virus-cell binding.
Monoclonal Antibody
PRO 140
Demonstrates Good Tolerability and Potent Activity against CCR5-tropic HIV
10/06/09
Newer Anti-HIV Drugs and How to Use Them: Part 2
6/26/09
Experimental HIV Entry Inhibitor
PRO 140
Demonstrates Favorable Activity in Phase 2 Trial
11/08/08
FDA-approved HIV
and AIDS Treatments
Protease Inhibitors
PIs
non Nucleoside Reverse
Transcriptase Inhibitors
nNRTIs
Nucleoside / Nucleotide
Reverse Transcriptase Inhibitors
NRTIs
Fixed-dose Combinations
Entry / Fusion Inhibitors
EIs
Integrase Inhibitors
Experimental Treatments
HIV and AIDS
Articles by Topic
Adverse Events
Opportunistic Infections
Metabolic Complications
Lipodystrophy - Fat Redistribution
Treatment Guidelines
Women/Children